SATS 2009 Final Program - Scandinavian Association for Thoracic ...

Recommendations

Info

Epic Stented Tissue Valve with Linx AC Technology FlexFit Implant System Advanced Technology for Long-Term Durability. Supported by 20-year published durability data for our Biocor valve and 25 years of Biocor clinical experience, the Epic valve offers the same design as the Biocor valve, with Linx AC Technology. A patented, proprietary anticalcification treatment, Linx AC is designed to improve long-term performance and valve durability.* For enhanced control during the entire implant procedure, the Epic valve also features the exclusive FlexFit system. SJMprofessional.com *There is no clinical data currently available which evaluates the long-term impact of anticalcification tissue treatment in humans. Biocor, Epic, FlexFit, Linx, ST. JUDE MEDICAL, the nine-squares symbol and MORE CONTROL. LESS RISK. are trademarks and service marks of St. Jude Medical, Inc. and its related companies. ©2009 St. Jude Medical. All Rights Reserved.
ABSTRACTS STOCKHOLM, SWEDEN 37
Page 1 and 2: Final Programme & Abstracts First J
Page 3 and 4: Table of contents Awards. . . . . .
Page 5 and 6: Transcatheter Valve CardioVascular.
Page 7 and 8: Programme overview Thursday, 20 Aug
Page 9 and 10: Saturday, 22 August 2009 SATS SCANS
Page 11 and 12: Scientific Programme THURSDAY, 20 A
Page 13 and 14: FRIDAY, 21 AUGUST 2009 08:30 - 10:3
Page 15 and 16: FRIDAY, 21 AUGUST 2009 11:00 - 11:3
Page 17 and 18: SATURDAY, 22 AUGUST 2009 08:30 - 10
Page 19 and 20: Cardiac lesions that work Cardiobla
Page 21 and 22: Introducing... V-Loc Advanced Woun
Page 23 and 24: Smoking policy Kistamässan and the
Page 25 and 26: ��
Page 27 and 28: Kistamässan Overview KONFERENS Fir
Page 29 and 30: M2 M1 Exhibition Floor Plan STOCKHO
Page 31 and 32: Authors' Index A Aasmundstad, Tor S
Page 33 and 34: R Raffa, Giuseppe S05:5 Raoul, Berg
Page 38 and 39: S01 SATS AWARD NOMINEES ORAL ABSTRA
Page 40 and 41: S01:5 THE NEW TNM STAGING SYSTEM FO
Page 42 and 43: S03:3 GABAPENTIN FOR POSTOPERATIVE
Page 44 and 45: S05 SATS CARDIAC ORAL ABSTRACT SESS
Page 46 and 47: S05:5 MINIMALLY INVASIVE REOPERATIV
Page 48 and 49: S06 SCANSECT ORAL ABSTRACT SESSION
Page 50 and 51: S06:4 IN VITRO COMPARISON OF THE NE
Page 52 and 53: S06:8 COAGULATION IN OXYGENATOR AND
Page 54 and 55: S07:3 SURGICAL TEAM MEMBER’S EXPE
Page 56 and 57: S07:7 ADDRESSING THE SPOUSES UNIQUE
Page 58 and 59: S09:3 THE NO TOUCH VEIN GRAFT HARVE
Page 60 and 61: S09:7 SURGICAL CORRECTION OF PECTUS
Page 62 and 63: S10:3 VALIDATION OF CYSTATIN C WITH
Page 64 and 65: S18 PHYSIOTHERAPISTS ORAL ABSTRACT
Page 66 and 67: P01 POSTER SESSION P01:01 PLATELET
Page 68 and 69: P01:04 RIGHT VENTRICULAR 3-D ARCHIT
Page 70 and 71: P01:08 THE EFFECT OF CO2-INSUFFLATI
Page 72 and 73: P01:12 REOPERATION FOR BLEEDING FOL
Page 74 and 75: P01:16 PNEUMONECTOMY FOR NON-SMALL
Page 76 and 77: P01:20 SURGICAL REVASCULARIZATION A
Page 78 and 79: P01:24 HOW DOES INTRAOPERATIVE ASSE
Page 80 and 81: P01:28 CORONARY ARTERY BYPASS GRAFT
Page 82 and 83: P01:32 RECIPIENT CELLS IN BRONCHIAL
Page 84 and 85: P01:36 ACUTE DYSFUNCTION OF MECHANI
Page 86 and 87:
P01:40 SVO2 A MARKER WITH EXCELLENT
Page 88 and 89:
P01:44 SUBCLAVIAN ARTERY APPROACH I
Page 90 and 91:
P01:48 NURSING STUDY 30 DAYS AFTER
Page 92 and 93:
Notes www.sats2009.org
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100:
www.sats2009.org
show all

SATS 2009 Final Program - Scandinavian Association for Thoracic ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?